Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma

Journal of Neurosurgery

Volumn 88, Issue 3, 1998, Pages 513-520

  Abdulrauf, Saleem I ^a,b   Edvardsen, Klaus ^a,c   Ho, Khang L ^a   Yang, Xiao Yi ^a   Rock, Jack P ^a   Rosenblum, Mark L ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Low grade astrocytoma; Prognostic marker; Survival; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

EID: 0031941942     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.88.3.0513     Document Type: Article

References (52)

1. Berger MS, Deliganis AV, Dobbins J, et al: The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784-1791, 1994
2. Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988
3. Fazakas JT: Treatment of grades I and II brain astrocytomas. The role of radiotherapy. Int J Radiat Oncol Biol Phys 2: 661-666, 1977
4. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32:2413-2422, 1996
5. Firsching R, Tieben R, Schröder R, et al: Long-term prognosis of low grade astrocytoma. Zentralbl Neurochir 55:10-15, 1994
6. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1762, 1995
7. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186, 1971
8. Gasparini G, Weidner N, Maluta S, et al: Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55: 739-744, 1993
9. Gerdes J, Becker MH, Key G, et al: Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 169:85-86, 1992 (Letter)
10. Goldman CK, Kim J, Wong WL, et al: Epidermal growth factor stimulates vascular endothelial growth factor production by human glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4:121-133, 1993
11. Graham CH, Rivers J, Kerbel RS, et al: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 145:510-514, 1994
12. Hollingsworth HC, Kohn EC, Steinberg SM, et al: Tumor ansiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147:33-41, 1995
13. Hsu D, Louis DN, Efird JT, et al: Use of Ki-67 (MIB-1) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 55:605, 1996 (Abstract)
14. Jaeger TM, Weidner N, Chew K, et al: Tumor angiogenesis and lymph node metastases in invasive bladder carcinoma. J Urol 151 (Suppl):348, 1994 (Abstract)
15. Janny P, Cure H, Mohr M, et al: Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer 73: 1937-1946, 1994
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Karnofsky DA, Abelmann WH, Craver LF, et al: The use of nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1:634-656, 1948
18. Kim KJ, Li B, Armanini M, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844, 1993
19. Kleihues P, Burger PC, Scheithauer RW: Histological Typing of Tumours of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993, pp 11-30
20. Laws ER Jr, Taylor WF, Clifton MB, et al: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673, 1984
21. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372, 1996
22. Li VW, Folkerth RD, Watanabe H, et al: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82-86, 1994
23. Macchiarini P, Fontanini G, Dulmet E, et al: Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann Thorac Surg 57:1534-1539, 1994
24. Macchiarini P, Fontanini G, Hardin MJ, et al: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1992
25. Maruno M, Kovach JS, Kelly PJ, et al: Transforming growth factor-α, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. J Neurosurg 75: 97-102, 1991
26. McCormack BM, Miller DC, Budzilovich GN, et al: Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31:636-642, 1992
27. Medbery CA III, Straus KL, Steinberg SM, et al: Low-grade astrocytomas: treatment results and prognostic variables. Int J Radiat Oncol Biol Phys 15:837-841, 1988
28. Miralbell R, Balart J, Matias-Guiu X, et al: Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters. Radiother Oncol 27:112-116, 1993
29. Nguyen M, Watanabe H, Budson AE, et al: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356-361, 1994
30. North CA, North RB, Epstein JA, et al: Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 66:6-14, 1990
31. Olivarez D, Ulbright T, DeRiese W, et al: Neovascularization in clinical stage. A testicular germ cell tumor: prediction of metastatic disease. Cancer Res 54:2800-2802, 1994
32. Philippon JH, Clemenceau SH, Fauchon FH, et al: Supratentorial low-grade astrocytomas in adults. Neurosurgery 32: 554-557, 1993
33. Piepmeier J, Christopher S, Spencer D, et al: Variations in the natural history and survival in patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872-879, 1996
34. Piepmeier JM: Observations on the current treatment of the low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 67:177-181, 1987
35. Pinkus GS, Etheridge CL, O'Connor EM: Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. Am J Clin Pathol 85:269-277, 1986
36. Plate KH, Breier G, Weich HA, et al: Vascular endothelial growth factor and glioma angiogenesis coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529, 1994
37. Saclarides TJ, Speziale NJ, Drab E, et al: Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37:921-926, 1994
38. Samoto K, Ikezaki K, Ono M, et al: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189-1193, 1995
39. Scanlon PW, Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery 5:301-308, 1979
40. Shaw EG, Daumas-Duport C, Scheithauer BW, et al: Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70:853-861, 1989
41. Shibamoto Y, Kitakabu Y, Takahashi M, et al: Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 72:190-195, 1993
42. Shweiki D, Itin A, Soffer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
43. Soffietti R, Chiò A, Giordana MT, et al: Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686-692, 1989
44. Suzuki K, Hayashi N, Miyamoto Y, et al: Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004-3009, 1996
45. Takahashi Y, Kitadai Y, Bucana CD, et al: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968, 1995
46. Takano S, Yoshii Y, Kondo S, et al: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56:2185-2190, 1996
47. Vacca A, Ribatti D, Roncali L, et al: Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87: 503-508, 1994
48. Wakui S, Furusato M, Itoh T, et al: Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 68:257-262, 1992
49. Weidner N, Carroll PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
50. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
51. Williams JK, Carlson GW, Cohen C, et al: Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373-380, 1994
52. Yamazaki K, Abe S, Takekawa H, et al: Tumor angiogenesis in human lung adenocarcinoma. Cancer 74:2245-2250, 1994